In Brief: FDA/industry grassroots meeting
This article was originally published in The Gray Sheet
Executive Summary
FDA/industry grassroots meeting: Nashville and New Orleans District Offices in FDA's Office of Regulatory Affairs are scheduled to hold a "Grassroots Regulatory Partnership Workshop" Dec. 16-17 in Nashville, Tennessee. The meeting is intended to "promote open dialogue between FDA and the medical device industry on quality system regulations and medical device reporting requirements," according to an Oct. 24 Federal Register notice. Registration must be received by FDA by Nov. 20. For further information, contact FDA's Rebecca Keenan at 615/781-5380, extension 145...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.